Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$12.97B
+41.1% from 2023
Prescriptions
10.4M
$1,245.09 per claim
Patients
2.0M
286,517 prescribers
Total spending, 2024
$12.97B
$6,642.45 per patient
Medicare prescription drug plans paid $12.97B for Ozempic in 2024, for 10,413,554 prescriptions and refills to 1,951,892 patients (up 41.1% from 2023). The average cost per claim was $1,245.09.
Texas had the highest Medicare cost for Ozempic in 2024: $1.18B for 912,298 claims, followed by California ($1.10B).
Eugenio Angueira-Serrano, endocrinology in Miami, FL, had the highest Medicare cost for Ozempic in 2024: 5,444 claims costing $5.8M.
Ozempic is made by Novo Nordisk A/S (NVO), listed in the Medicare spending data as Novo Nordisk.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Eugenio Angueira-Serrano Miami, FL | Endocrinology | 5,444 | 885 | $5.8M |
| Stella Ilyayeva Rego Park, NY | Internal Medicine | 3,061 | 582 | $3.2M |
| Monica G Robles |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 179,831 | 3,410,067 | 780,031 | $4.63B |
| 2023 | 254,476 | 6,925,667 | 1,463,887 | $9.19B |
| 2024 | 286,517 | 10,413,554 | 1,951,892 | $12.97B |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Endocrinology |
| 1,675 |
| 379 |
| $2.5M |
| Syed A Hassan Harlingen, TX | Endocrinology | 1,506 | 380 | $2.4M |
| Bashar G Saad San Dimas, CA | Endocrinology | 2,138 | 447 | $2.4M |
| Lane M Frey Thibodaux, LA | Endocrinology | 1,296 | 306 | $2.3M |
| Ronald B Villanueva Lakewood, NJ | Endocrinology | 1,154 | 292 | $2.3M |
| Stephan Kowalyk Greensburg, PA | Endocrinology | 1,983 | 348 | $2.3M |
| Kandaswamy Jayaraj Beaumont, TX | Endocrinology | 1,321 | 301 | $2.1M |
| Brian E Burtch Willoughby, OH | Endocrinology | 1,281 | 308 | $2.0M |
| Cheng-Yang C Tuan San Francisco, CA | Endocrinology | 1,180 | 260 | $2.0M |
| Vinay Kapoor Bayside, NY | Endocrinology | 994 | 243 | $1.9M |
| Irina A Urusova Los Angeles, CA | Endocrinology | 1,999 | 256 | $1.9M |
| Alisha Mason Ripley, MS | Family Practice | 724 | 280 | $1.9M |
| Phong H Bui Fountain Valley, CA | Internal Medicine | 1,314 | 230 | $1.9M |
| Ralph Oiknine Chesterfield, MO | Endocrinology | 1,073 | 243 | $1.9M |
| Juan D Palacios Merchan Edinburg, TX | Endocrinology | 1,382 | 268 | $1.8M |
| Farhad Farjoudi San Diego, CA | Endocrinology | 1,165 | 273 | $1.8M |
| Ahmed F Al Jebawi Anderson, IN | Endocrinology | 1,152 | 252 | $1.8M |
| Kalyani Regeti North Port, FL | Endocrinology | 903 | 233 | $1.8M |
| Sharon H Kim Bronx, NY | Endocrinology | 1,256 | 233 | $1.7M |
| Ahmet B Ergin Port St Lucie, FL | Endocrinology | 1,108 | 278 | $1.7M |
| Anju Gurung Fayetteville, NC | Internal Medicine | 1,017 | 222 | $1.7M |
| Benito A Marranzini El Paso, TX | Endocrinology | 905 | 236 | $1.7M |
| Nidhi Jain Little Rock, AR | Endocrinology | 1,539 | 280 | $1.7M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Novo Nordisk NVO | 10,417,182 | $12.97B |